Calamos Advisors LLC boosted its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 5.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,526 shares of the financial services provider’s stock after acquiring an additional 2,106 shares during the period. Calamos Advisors LLC’s holdings in CME Group were worth $11,969,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Whipplewood Advisors LLC raised its holdings in CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares during the last quarter. Asset Dedication LLC boosted its stake in shares of CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 37 shares during the last quarter. FNY Investment Advisers LLC bought a new stake in shares of CME Group in the 4th quarter valued at $27,000. Elkhorn Partners Limited Partnership acquired a new stake in shares of CME Group during the fourth quarter worth $27,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of CME Group during the fourth quarter worth $28,000. Institutional investors and hedge funds own 87.75% of the company’s stock.
CME Group Trading Down 0.6%
CME opened at $243.61 on Wednesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The firm has a market capitalization of $88.27 billion, a PE ratio of 20.79, a P/E/G ratio of 2.89 and a beta of 0.25. The company’s 50-day moving average is $260.94 and its 200 day moving average is $282.82.
CME Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is currently 44.37%.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft lowered their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Morgan Stanley decreased their price target on CME Group from $353.00 to $324.00 and set an “overweight” rating for the company in a report on Friday, July 10th. Raymond James Financial reissued an “outperform” rating and issued a $320.00 price objective on shares of CME Group in a research report on Thursday, July 2nd. Piper Sandler set a $320.00 price objective on CME Group in a research report on Wednesday, June 17th. Finally, Jefferies Financial Group dropped their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research note on Thursday, April 9th. Twelve investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, CME Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $293.59.
Insider Activity
In related news, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles
- Five stocks we like better than CME Group
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
